Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
334M
-
Number of holders
-
249
-
Total 13F shares, excl. options
-
141M
-
Shares change
-
+17.8M
-
Total reported value, excl. options
-
$3.88B
-
Value change
-
+$484M
-
Put/Call ratio
-
0.52
-
Number of buys
-
156
-
Number of sells
-
-93
-
Price
-
$27.45
Significant Holders of IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) as of Q2 2020
310 filings reported holding IOVA - IOVANCE BIOTHERAPEUTICS, INC. - Common Stock as of Q2 2020.
IOVANCE BIOTHERAPEUTICS, INC. - Common Stock (IOVA) has 249 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 141M shares
of 334M outstanding shares and own 42.1% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (12.2M shares), PERCEPTIVE ADVISORS LLC (11.8M shares), Avoro Capital Advisors LLC (10.4M shares), BlackRock Inc. (9.69M shares), PRICE T ROWE ASSOCIATES INC /MD/ (7.27M shares), FRANKLIN RESOURCES INC (6.96M shares), ORBIMED ADVISORS LLC (6.65M shares), FARALLON CAPITAL MANAGEMENT LLC (6.54M shares), ARK Investment Management LLC (4.24M shares), and GREAT POINT PARTNERS LLC (3.72M shares).
This table shows the top 249 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.